Supplements sold to strengthen the gut lining have converged on a similar formula: a butyrate precursor, one or two next-generation probiotic strains, and a claim about the intestinal barrier. The ingredients are real and several have genuine science behind them. The claim being made is not the claim that was tested.
Sorting this out means separating three things that marketing copy blends together: what has been shown in cells, what has been shown in people, and what has been shown for the finished product at the dose in the capsule.
The Verdict
What the ingredients are, and what has been shown
| Ingredient | What it is | Human evidence | Where it lands |
|---|---|---|---|
| Tributyrin, sold under ingredient brands including CoreBiome | A butyrate precursor that survives the stomach and releases butyrate further down the tract | Barrier and tight-junction effects demonstrated in cell and tissue models. A 2024 pilot study in humans found no significant effects on gut measures in a healthy group | Mechanistically plausible, human barrier evidence not established |
| Sodium butyrate | Butyrate delivered directly | Acute reduction of induced hyperpermeability shown in human colonic tissue studied outside the body. Human trials report mixed results on permeability markers | Some direct human tissue evidence, limited whole-person outcome data |
| Akkermansia muciniphila, pasteurized | A mucin-degrading species that thrives in the mucus layer | A 2019 proof-of-concept study in 32 completers over three months improved insulin sensitivity by about 29% and reduced total cholesterol by about 9%. Later randomized work has targeted weight and metabolic endpoints | The best human data of the group, on metabolic rather than barrier endpoints |
| Bifidobacterium longum BB536 | A well-characterised probiotic strain | Studied mainly for stool regularity, immune measures, and tolerability rather than for barrier repair | Established strain, different endpoint from the one being marketed |
| Lactiplantibacillus plantarum strains | Common probiotic species with strain-specific effects | Some strains show tight-junction effects in models. Strain-level human barrier data is thin | Strain matters, and evidence rarely transfers between strains |
| L-glutamine, zinc carnosine, collagen peptides | The older generation of gut lining ingredients | Glutamine has evidence in specific clinical contexts such as critical illness. Zinc carnosine has small studies. Collagen peptides have no barrier evidence in humans | Context-specific at best, and the marketed context is not the studied one |
The pattern across that table is consistent and worth naming directly. The barrier evidence is strongest in models and weakest in people. The people evidence is strongest for endpoints that are not the barrier at all. Akkermansia has the best human data of the group, and that data is about insulin sensitivity and cholesterol.
That is not a reason to dismiss the ingredients. Improving insulin sensitivity is a worthwhile outcome, and it is arguably a better reason to be interested in Akkermansia than the claim on the label. It is a reason to buy on the evidence that exists rather than the evidence being implied.
Grading the common claims
| The claim | What the evidence supports | The question it avoids |
|---|---|---|
| "Repairs your gut lining" | No supplement has been shown to repair intestinal barrier structure in healthy adults in a controlled trial | The barrier in a healthy adult is not established to be damaged in the first place |
| "Reduces leaky gut" | Increased intestinal permeability is a genuine phenomenon in coeliac disease, inflammatory bowel disease, and critical illness. It is not an established diagnosis in otherwise well people | The condition being treated is usually not measured before or after |
| "Clinically proven ingredients" | The ingredient may have clinical studies. The finished product at its actual dose almost never does | Ingredient evidence and product evidence are different claims |
| "Personalised to your microbiome" | Stool sequencing describes which organisms are present. It does not establish which supplement will help | No test currently validates a supplement recommendation against an outcome |
| "Increases butyrate by 46x" | Multiplier claims of this kind typically come from laboratory or simulated digestion models, not from measurements in people | Ask what was measured, in what, and against what comparator |
The multiplier claims deserve a closer look because they are persuasive and rarely explained. A figure like a 46-fold increase in butyrate typically comes from a simulated digestion model or a fermentation vessel, where the comparison is between a formulation and a blank rather than between people who took the product and people who did not. The number can be accurate and still tell you nothing about what happens in your colon.
The personalisation claim has a similar structure. Stool sequencing genuinely identifies which organisms are present in a sample. What it has not been shown to do is predict which intervention will help a given person, which is the step that would make a recommendation personalised in any meaningful sense. Our guide to whether gut health tests are accurate covers the measurement side, and how to pick a gut health test covers what the panels can and cannot answer.
When barrier function genuinely matters
| Situation | What is established | What follows |
|---|---|---|
| Coeliac disease | Permeability is genuinely increased, and the established treatment is a strict gluten-free diet | Diagnosis first. Supplements do not substitute for the dietary treatment |
| Inflammatory bowel disease | Barrier dysfunction is part of the disease process | Managed by a gastroenterologist. Adjunct supplements are a clinical decision, not a self-directed one |
| Post-infectious and post-antibiotic disturbance | Transient changes are well documented and usually resolve | Time and diet do most of the work. Specific probiotic strains have some evidence for antibiotic-associated diarrhoea |
| Critical illness and major surgery | The clinical setting where glutamine and barrier-directed nutrition have been studied seriously | Inpatient context, not a consumer one |
| Persistent symptoms with no diagnosis | The situation most people buying these products are actually in | Worth investigating properly. Coeliac serology, inflammatory markers, and a symptom history change management more often than a supplement does |
The last row is the important one, because it describes most people who reach a page like this. Bloating, irregularity, fatigue, and food reactions are real symptoms with a long list of causes, and the list includes several things that respond well to treatment. Coeliac disease is the clearest example: it is common, frequently undiagnosed for years, genuinely does increase intestinal permeability, and has an established treatment. Serology is inexpensive, and it must be done while still eating gluten to be interpretable.
Across the gut testing products we assess on a single rubric, the recurring pattern is that panels are sold on measurement sophistication while the recommendations attached to them are generic. A sequencing report can be technically excellent and still return advice that would be the same for anyone: more fibre, more plant variety, less alcohol. That advice happens to be correct, which is a separate matter from whether the test was needed to produce it.
What the evidence supports doing
- Get a diagnosis before treating a mechanism. Coeliac serology, inflammatory markers, and a proper symptom history identify treatable causes that no supplement addresses.
- Feed butyrate production rather than buying it. Varied dietary fibre supports the colonic bacteria that produce butyrate, which is the same molecule these products deliver, with far better evidence behind the approach.
- Judge a probiotic at strain level. Evidence for one strain does not transfer to another in the same species. If the label names only a species, the studies attached to it may not apply to what is in the bottle.
- Buy Akkermansia for the endpoint it was studied on, if at all. The human data concerns insulin sensitivity and lipids, not barrier repair, and comes from a small exploratory trial.
- Be sceptical of tests sold alongside the supplement. The commercial permeability markers are not well validated, and a test that cannot establish the problem cannot demonstrate that it was fixed.
See a clinician for blood in the stool, unintended weight loss, persistent vomiting, a change in bowel habit lasting more than a few weeks, symptoms starting after age 50, or a family history of bowel cancer or inflammatory bowel disease. Each of those is a reason for assessment rather than another supplement.
Frequently Asked Questions
Do gut lining supplements work?
No supplement has been shown in a controlled human trial to repair the intestinal barrier in healthy adults. The mechanistic case for butyrate and certain probiotic strains is reasonable and supported by cell and tissue studies, but the human evidence does not currently follow through. A 2024 pilot study of a butyrate-generating supplement in healthy people found no significant supplementation-related effects on gut measures, and the authors called for studies in people with genuinely compromised intestinal integrity. That is where the evidence gap sits.
Is leaky gut a real condition?
Increased intestinal permeability is real and measurable in specific diseases, including coeliac disease, inflammatory bowel disease, and critical illness. "Leaky gut syndrome" as a standalone diagnosis in otherwise healthy people is not recognised in clinical practice, and there is no validated test to diagnose it. The distinction matters because the treatments that work in the established conditions treat the underlying disease rather than the permeability itself.
Can I test whether my gut lining is damaged?
Not reliably outside a research or specialist setting. Commercial panels commonly sell blood or stool zonulin as a permeability measure, and independent analyses have questioned what the widely used assays actually detect. Lactulose-mannitol ratio testing is the better-validated approach and is used in research rather than routine care. Our page on how doctors test gut health covers what clinicians actually order and what those tests answer.
What does the Akkermansia evidence actually show?
The strongest human study, published in 2019, was an exploratory proof-of-concept trial in overweight and insulin-resistant adults, with 40 enrolled and 32 completing three months. Pasteurized Akkermansia muciniphila improved insulin sensitivity by roughly 29%, reduced fasting insulin by roughly 34%, and lowered total cholesterol by about 9%, with small reductions in weight and fat mass. It was well tolerated. Those are metabolic endpoints. The trial was not designed to show barrier repair, and later randomized work has continued to focus on weight and metabolic outcomes.
Does butyrate supplementation raise butyrate in the colon?
Delivery is the harder problem than the claim suggests. Butyrate is absorbed high in the tract, which is why tributyrin and coated formulations exist. Studies in cell and tissue models show butyrate supports tight-junction proteins, and a study in human colonic tissue examined outside the body showed acute reduction of induced hyperpermeability. Whether an oral dose reaches the relevant tissue at a relevant concentration in a living person, and changes anything measurable, is the step the evidence has not closed.
What actually improves gut barrier function?
The interventions with the most support are unglamorous. Dietary fibre from varied plant sources feeds the bacteria that produce butyrate in the colon, which is the same molecule these supplements deliver in a bottle. Treating the underlying condition matters most where one exists, such as a gluten-free diet in coeliac disease. Adequate sleep, moderate alcohol intake, and avoiding unnecessary antibiotics all have supporting evidence. None of these is a product, which is part of why they are marketed less.
Related
- How doctors test gut health — the tests clinicians actually order
- Are gut health tests accurate? — the measurement versus the advice
- Best gut health test — how to pick, and when to skip
- Viome review — one sequencing platform assessed on the rubric
- Viome vs Zoe — two approaches to the same question
- Supplements — what the evidence supports across the category